Stock screener

NEOG

Conviction 87HealthcareScan · Mon, Aug 10, 2026
NEOG$11.40-0.61%
ResistanceSupportVol 14
63 bars
Vol MA14 2.76M
May 11May 28Jun 16Jul 6Jul 23Aug 10
NEOGEN CORPIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.neogen.com ↗
Price11.40
Change-0.61%
Gap-0.74%
Rel volume1.34×
Avg volume2.4M
Avg $ vol25.92M
SMA 2010.49
SMA 509.72
SMA 2008.84
Price vs 50+17.30%
Price vs 200+28.92%
MA stackbullish
50/200 cross—
Supertrendup · 10.53
RSI (14)64
MACD hist0.10
MACD crossbull · 7d
Stoch %K / %D62 / 62
ADX (14)27
+DI / −DI37 / 18
RSI divergence—
MACD divergence—
ATR %+4.34%
ADR %4.30%
52w high12.04
52w low5.08
From 52w high-5.32%
Above 52w low+124.41%
New 52w highNo
SqueezeOff
Bollinger width36.81%
%B0.74
Donchian pos61.84%
Donchian high12.85
Donchian low9.05
AVWAP (52w high)11.71
vs AVWAP high-2.63%
AVWAP (52w low)7.66
vs AVWAP low+48.73%
OBV trendDown
Chaikin MF (20)-0.05
Today vs 20d1.34×
Avg vol (14d)2.76M
Avg vol (20d)2.4M
Avg $ vol (20d)25.92M
Market cap—
RS 3m (vs SPY)+18.30%
RS 6m (vs SPY)-5.80%
RS line new highNo
Trend template8/8
Technical rank79.3
1 week-4.20%
1 month+18.50%
3 months+25.97%
6 months+5.56%
1 year+128.00%
YTD+62.86%
P/E-316.46
P/B1.19
P/S2.87
P/FCF30.60
EPS-0.0400
Div yield—
ROE-0.38%
ROA-0.24%
Debt/Eq0.38
Current3.82
EV/EBITDA32.82
Gross margin46.93%
Net margin-0.91%
Rev growth-2.72%
EPS growth99.28%
Price target12.50
Target upside9.03%
Analyst ratingHold
Institutional125.93%
Ent. value3.11B
Revenue211.2M
Net income-17M
Gross profit99M
Free cash flow81.7M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out217.67M
Employees1.46K
ListedWed, Aug 23, 1989
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction87 / 100
Pattern quality—
Tech rank79.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance11.64
Support8.72
Days since event—
Candle confirm—
News sentiment—

Financials as of Sat, Feb 28, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jul 1 – Jul 8
    4 scans
  2. Breaking out now
    Jul 9
    1 scan
  3. Broke out
    Jul 10
    1 scan

Congress activity

Disclosed STOCK Act trades in NEOG

All disclosures →
No recent disclosed trades by Congress in NEOG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NEOG · 4 buys · 5 sells

InsiderSideShares
Moylan John Patrick
Chief Accounting Officer · Restricted Stock Units · 2026-06-03
Tax2.55K
Rocklin Amy M
Former Chief Legal Officer · Common Stock · 2026-05-18
Exercise35.18K
Rocklin Amy M
Former Chief Legal Officer · Restricted Stock Units · 2026-05-18
Exercise35.18K
Rocklin Amy M
Former Chief Legal Officer · Common Stock · 2026-05-18
Tax10.24K
Moylan John Patrick
Chief Accounting Officer · Restricted Stock Units · 2026-05-04
Exercise4.56K
Moylan John Patrick
Chief Accounting Officer · Common Stock · 2026-05-04
Tax1.57K
Moylan John Patrick
Chief Accounting Officer · Common Stock · 2026-05-04
Exercise4.56K
Stacey Jennifer Evans
Chief Legal Officer · Common Stock · 2026-05-01
Grant39.35K
Stacey Jennifer Evans
Chief Legal Officer · Common Stock (Right to Buy) · 2026-05-01
Grant89.52K

SEC filings

EDGAR filings in NEOG · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.